[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Clofarabine.]
[J01GA01, streptomycin, Clofarabine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Clofarabine.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Clofarabine.]
[L04AA27, fingolimod, Clofarabine may increase the immunosuppressive activities of Fingolimod.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01CG01, sulbactam, Clofarabine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Clofarabine.]
[M04AB02, sulfinpyrazone, The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Clofarabine.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Mercaptopurine.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Teniposide is combined with Clofarabine.]
[R03CC03, terbutaline, Clofarabine may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Clofarabine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The excretion of Clofarabine can be increased when combined with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Tetracaine.]
[S03AA02, tetracycline, The excretion of Clofarabine can be decreased when combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Clofarabine may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[A11DA01, thiamine, The serum concentration of Clofarabine can be increased when it is combined with Thiamine.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Eribulin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Clofarabine is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Clofarabine.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Clofarabine.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Thioridazine.]
[G04BE06, moxisylyte, Clofarabine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Clofarabine may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The risk or severity of bleeding can be increased when Ticlopidine is combined with Clofarabine.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Timolol is combined with Clofarabine.]
[P01AB02, tinidazole, Clofarabine may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Clofarabine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Clofarabine may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[M02AX02, tolazoline, The risk or severity of adverse effects can be increased when Clofarabine is combined with Tolazoline.]
[V04CA01, tolbutamide, Clofarabine may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the orthostatic hypotensive activities of Clofarabine.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Clofarabine.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Triamcinolone is combined with Clofarabine.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Clofarabine may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Clofarabine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Clofarabine.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Mometasone.]
[A03AA05, trimebutine, Clofarabine may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[C02BA01, trimethaphan, Clofarabine may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The serum concentration of Clofarabine can be increased when it is combined with Trimethoprim.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Clofarabine is combined with Azilsartan medoxomil.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Clofarabine.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Belimumab.]
[L01FX04, ipilimumab, Clofarabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The serum concentration of Clofarabine can be increased when it is combined with Vandetanib.]
[R02AA14, oxyquinoline, Clofarabine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The serum concentration of Clofarabine can be increased when it is combined with Linagliptin.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Clofarabine.]
[S01AA28, vancomycin, Clofarabine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Clofarabine is combined with Belatacept.]
[N03AX21, ezogabine, Clofarabine may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Clofarabine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The risk or severity of bleeding can be increased when Ticagrelor is combined with Clofarabine.]
[C08DA01, verapamil, The risk or severity of adverse effects can be increased when Clofarabine is combined with Verapamil.]
[N06AX09, viloxazine, Clofarabine may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Vinblastine is combined with Clofarabine.]
[C04AX07, vincamine, Clofarabine may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Vincristine is combined with Clofarabine.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Clofarabine.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Clofarabine.]
[B01AA03, warfarin, Clofarabine may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Clofarabine.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Brentuximab vedotin.]
[M05BA05, tiludronic acid, Clofarabine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Clofarabine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The serum concentration of Clofarabine can be increased when it is combined with Crizotinib.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Clofarabine.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Clofarabine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Clofarabine.]
[N02BA01, aspirin, The excretion of Clofarabine can be decreased when combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ruxolitinib.]
[G04BD07, tolterodine, Clofarabine may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Clofarabine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Atenolol is combined with Clofarabine.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Clofarabine.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Clofarabine.]
[M01CB03, auranofin, Clofarabine may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Clofarabine is combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Clofarabine.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Clofarabine.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[G04BE10, avanafil, Avanafil may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Clofarabine.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Clofarabine.]
[A08AA11, lorcaserin, Clofarabine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Clofarabine may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Carfilzomib.]
[V03AX03, cobicistat, Cobicistat may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L02BB04, enzalutamide, Clofarabine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Bosutinib.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Clofarabine.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Clofarabine is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Aldosterone.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Clofarabine.]
[D02BA02, octinoxate, Clofarabine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, Nelfinavir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Bendamustine.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Clofarabine.]
[C08CA13, lercanidipine, The risk or severity of adverse effects can be increased when Lercanidipine is combined with Clofarabine.]
[L04AA29, tofacitinib, Clofarabine may increase the immunosuppressive activities of Tofacitinib.]
[V09IX04, fluorodeoxyglucose F18, Clofarabine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Sildenafil is combined with Clofarabine.]
[V08CA11, gadofosveset, Clofarabine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ponatinib.]
[B01AF02, apixaban, The risk or severity of bleeding can be increased when Apixaban is combined with Clofarabine.]
[A16AX08, teduglutide, Clofarabine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Clofarabine may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Clofarabine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pomalidomide.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dimethyl fumarate.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Benzocaine.]
[L03AA12, ancestim, Clofarabine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Clofarabine is combined with Everolimus.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Clofarabine can be increased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01EE01, trametinib, Clofarabine may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Clofarabine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06AX28, levomilnacipran, Clofarabine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[J05AJ03, dolutegravir, The serum concentration of Clofarabine can be increased when it is combined with Dolutegravir.]
[C08EA02, bepridil, The risk or severity of adverse effects can be increased when Clofarabine is combined with Bepridil.]
[C02KX05, riociguat, The risk or severity of adverse effects can be increased when Clofarabine is combined with Riociguat.]
[L03AA14, lipegfilgrastim, Clofarabine may increase the myelosuppressive activities of Lipegfilgrastim.]
[A10BJ03, lixisenatide, Clofarabine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The excretion of Clofarabine can be decreased when combined with Cholic Acid.]
[C02KX04, macitentan, Clofarabine may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ibrutinib.]
[N06AX26, vortioxetine, Clofarabine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J05AP05, simeprevir, Simeprevir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J05AP08, sofosbuvir, Clofarabine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Clofarabine may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Acebutolol.]
[N05CH03, tasimelteon, Clofarabine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, The risk or severity of adverse effects can be increased when Clofarabine is combined with Apremilast.]
[L02BG02, formestane, Clofarabine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Clofarabine.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Betaxolol is combined with Clofarabine.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Clofarabine.]
[V03AB34, fomepizole, Clofarabine may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Clofarabine may increase the hypotensive activities of Bethanidine.]
[L04AC11, siltuximab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Siltuximab.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Vorapaxar is combined with Clofarabine.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Vedolizumab.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Acenocoumarol is combined with Clofarabine.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Clofarabine is combined with Belinostat.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Idelalisib.]
[N07XX08, tafamidis, The serum concentration of Clofarabine can be increased when it is combined with Tafamidis.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Empagliflozin.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Clofarabine is combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Decitabine.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pirfenidone.]
[S03AA06, gentamicin, Clofarabine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Blinatumomab.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Olaparib.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Dicoumarol is combined with Clofarabine.]
[B01AF03, edoxaban, Clofarabine may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L04AC10, secukinumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Palbociclib.]
[L01EX08, lenvatinib, The serum concentration of Clofarabine can be increased when it is combined with Lenvatinib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Clofarabine is combined with Panobinostat.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Clofarabine.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Tioclomarol is combined with Clofarabine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Clofarabine.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, The excretion of Clofarabine can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Clofarabine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Trabectedin.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Mepolizumab.]
[J02AC05, isavuconazole, The serum concentration of Clofarabine can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Clofarabine.]
[L01XG03, ixazomib, Clofarabine may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AC27, selexipag, Clofarabine may increase the hypotensive activities of Selexipag.]
[M04AB05, lesinurad, Clofarabine may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N03AX23, brivaracetam, Clofarabine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ixekizumab.]
[L01XX52, venetoclax, Venetoclax may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N05BA08, bromazepam, Clofarabine may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Clofarabine may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C08CA01, amlodipine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Clofarabine.]
[C03CA02, bumetanide, The excretion of Clofarabine can be decreased when combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Bupivacaine.]
[C07AA19, bupranolol, Clofarabine may increase the hypotensive activities of Bupranolol.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Arsenic trioxide.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Brodalumab.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Clofarabine.]
[A06AH05, naldemedine, Clofarabine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Clofarabine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Clofarabine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Clofarabine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Clofarabine.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Linezolid is combined with Clofarabine.]
[J05AF06, abacavir, Clofarabine may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Clofarabine may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The risk or severity of adverse effects can be increased when Infliximab is combined with Clofarabine.]
[L01ED04, brigatinib, Brigatinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Clofarabine.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Sarilumab.]
[J01MA23, delafloxacin, Clofarabine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Clofarabine.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Capecitabine.]
[L01XX59, enasidenib, The serum concentration of Clofarabine can be increased when it is combined with Enasidenib.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Clofarabine is combined with Vorinostat.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Bisoprolol is combined with Clofarabine.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Clofarabine.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Clofarabine.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Clofarabine.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nesiritide.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Clofarabine.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J05AX18, letermovir, The excretion of Clofarabine can be decreased when combined with Letermovir.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Clofarabine may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Clofarabine is combined with Captopril.]
[L02BB05, apalutamide, The serum concentration of Clofarabine can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Clofarabine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Clofarabine.]
[C07AG02, carvedilol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B02BX08, avatrombopag, The excretion of Clofarabine can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Baricitinib.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DD14, ceftibuten, The excretion of Clofarabine can be decreased when combined with Ceftibuten.]
[J01GB14, plazomicin, Clofarabine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Clofarabine may increase the hypotensive activities of Celiprolol.]
[P01BA07, tafenoquine, The serum concentration of Clofarabine can be increased when it is combined with Tafenoquine.]
[A16AX14, migalastat, Clofarabine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The excretion of Clofarabine can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Clofarabine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA39, emapalumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Clofarabine.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ravulizumab.]
[A06AX05, prucalopride, Clofarabine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Clofarabine is combined with Cilazapril.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Clofarabine.]
[B01AC23, cilostazol, The risk or severity of bleeding can be increased when Cilostazol is combined with Clofarabine.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Clofarabine is combined with Siponimod.]
[N06BA14, solriamfetol, Clofarabine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The serum concentration of Clofarabine can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Cloprednol.]
[C09CA06, candesartan, Clofarabine may increase the hypotensive activities of Candesartan.]
[L04AB01, etanercept, The risk or severity of adverse effects can be increased when Etanercept is combined with Clofarabine.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Risankizumab.]
[J01DC04, cefaclor, The excretion of Clofarabine can be decreased when combined with Cefaclor.]
[J01DB05, cefadroxil, The excretion of Clofarabine can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Clofarabine can be decreased when combined with Cefamandole.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DB04, cefazolin, The excretion of Clofarabine can be decreased when combined with Cefazolin.]
[L02BB06, darolutamide, Darolutamide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DD12, cefoperazone, The excretion of Clofarabine can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Clofarabine can be decreased when combined with Cefotaxime.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DC07, cefotiam, The excretion of Clofarabine can be decreased when combined with Cefotiam.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, The excretion of Clofarabine can be decreased when combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The excretion of Clofarabine can be decreased when combined with Ceftriaxone.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Upadacitinib.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N07XX11, pitolisant, Clofarabine may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DB01, cephalexin, The excretion of Clofarabine can be decreased when combined with Cephalexin.]
[J01DB02, cephaloridine, The excretion of Clofarabine can be decreased when combined with Cefaloridine.]
[J01DB03, cephalothin, The excretion of Clofarabine can be decreased when combined with Cefalotin.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Clofarabine is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Clofarabine.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Trastuzumab emtansine.]
[N02CC08, lasmiditan, The serum concentration of Clofarabine can be increased when it is combined with Lasmiditan.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Clofarabine is combined with Diroximel fumarate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M09AX08, golodirsen, Clofarabine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Clofarabine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Teprotumumab.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ozanimod.]
[R02AA03, dichlorobenzyl alcohol, Clofarabine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Clofarabine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Clofarabine.]
[C08CA16, clevidipine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Clofarabine can be increased when it is combined with Dronedarone.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Clofarabine.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Clofarabine.]
[C02AA06, methoserpidine, Clofarabine may increase the hypotensive activities of Methoserpidine.]
[L01EH03, tucatinib, The serum concentration of Clofarabine can be increased when it is combined with Tucatinib.]
[L01EX17, capmatinib, The serum concentration of Clofarabine can be increased when it is combined with Capmatinib.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Opicapone.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluprednidene.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[V08CA05, mangafodipir, Clofarabine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Clofarabine.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Clofarabine is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Stepronin.]
[C08CA17, levamlodipine, Clofarabine may increase the hypotensive activities of Levamlodipine.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AC19, satralizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Satralizumab.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The serum concentration of Clofarabine can be increased when it is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Clofarabine.]
[A10BB02, chlorpropamide, Clofarabine may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N02BA03, choline salicylate, The serum concentration of Clofarabine can be increased when it is combined with Choline salicylate.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fludarabine.]
[M01AX25, chondroitin sulfates, Clofarabine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[J05AJ04, cabotegravir, The excretion of Clofarabine can be decreased when combined with Cabotegravir.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Voclosporin.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Clofarabine is combined with Vericiguat.]
[L01EX21, tepotinib, Tepotinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[V03AF12, trilaciclib, The serum concentration of Clofarabine can be increased when it is combined with Trilaciclib.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fenoldopam.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Clofarabine.]
[N02BG07, flupirtine, Clofarabine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ponesimod.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Clofarabine.]
[H04AA02, dasiglucagon, Clofarabine may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The serum concentration of Clofarabine can be increased when it is combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01XX73, sotorasib, The serum concentration of Clofarabine can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, Ciprofloxacin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Clofarabine.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pegcetacoplan.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Clofarabine is combined with Belumosudil.]
[P01CA03, fexinidazole, The serum concentration of Clofarabine can be increased when it is combined with Fexinidazole.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Anifrolumab.]
[V09AB03, ioflupane I-123, Clofarabine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Clofarabine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Clofarabine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ropeginterferon alfa-2b.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Clofarabine.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Clofarabine can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Clomipramine.]
[N03AE01, clonazepam, Clofarabine may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The risk or severity of adverse effects can be increased when Clonidine is combined with Clofarabine.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J02AC06, oteseconazole, The serum concentration of Clofarabine can be increased when it is combined with Oteseconazole.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Deucravacitinib.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Clofarabine is combined with Clozapine.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01GB12, arbekacin, Clofarabine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Cocaine.]
[C02KB01, metyrosine, Clofarabine may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M04AC01, colchicine, Clofarabine may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Clofarabine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Clofarabine is combined with Desflurane.]
[A04AA03, tropisetron, Clofarabine may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Clofarabine may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nelarabine.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Clofarabine.]
[J05AB14, valganciclovir, Clofarabine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Clofarabine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Clofarabine may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Clofarabine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Clofarabine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Clofarabine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N02CC05, almotriptan, Clofarabine may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J02AC02, itraconazole, Itraconazole may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Clofarabine.]
[S01AD03, acyclovir, The excretion of Clofarabine can be decreased when combined with Acyclovir.]
[N05BA10, ketazolam, Clofarabine may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Imatinib is combined with Clofarabine.]
[A02BC05, esomeprazole, The excretion of Clofarabine can be decreased when combined with Esomeprazole.]
[C08CA09, lacidipine, Clofarabine may increase the hypotensive activities of Lacidipine.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Clofarabine.]
[N03AX09, lamotrigine, The serum concentration of Clofarabine can be increased when it is combined with Lamotrigine.]
[N07BC04, lofexidine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Lofexidine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Clofarabine is combined with Lisinopril.]
[A06AD01, magnesium carbonate, Clofarabine may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Clofarabine may increase the hypotensive activities of Manidipine.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Meprednisone.]
[J01DH02, meropenem, Clofarabine may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Clofarabine may decrease the excretion rate of Melperone which could result in a higher serum level.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Clofarabine.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Clofarabine.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Clofarabine.]
[S01XA18, cyclosporine, Clofarabine may increase the immunosuppressive activities of Cyclosporine.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Clofarabine.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Clofarabine is combined with Moexipril.]
[C10AA07, rosuvastatin, The excretion of Clofarabine can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Moxonidine.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Cytarabine.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Clofarabine.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dactinomycin.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Daunorubicin.]
[C02CC04, debrisoquin, Clofarabine may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Clofarabine.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N07BB05, nalmefene, Clofarabine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nebivolol.]
[S01GX04, nedocromil, Clofarabine may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Clofarabine may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Clofarabine.]
[L02BB02, nilutamide, Clofarabine may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Clofarabine.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06AA01, desipramine, The serum concentration of Clofarabine can be increased when it is combined with Desipramine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Clofarabine.]
[V04CH02, indigo carmine, Clofarabine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Clofarabine is combined with Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Clofarabine.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dexamethasone.]
[L04AB04, adalimumab, The risk or severity of adverse effects can be increased when Adalimumab is combined with Clofarabine.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AC04, clopidogrel, The serum concentration of Clofarabine can be increased when it is combined with Clopidogrel.]
[P03AC04, permethrin, Clofarabine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Clofarabine may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Diazoxide.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Cinchocaine.]
[R05DA08, pholcodine, Clofarabine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The excretion of Clofarabine can be decreased when combined with Diclofenac.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[A03AA07, dicyclomine, Clofarabine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Clofarabine may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Clofarabine may increase the hypotensive activities of Pinacidil.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pipamperone.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ixabepilone.]
[L01EB02, erlotinib, Erlotinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pirarubicin.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C08CA03, isradipine, The risk or severity of adverse effects can be increased when Isradipine is combined with Clofarabine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Difluocortolone.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C01AA05, digoxin, Clofarabine may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Clofarabine may increase the hypotensive activities of Dihydralazine.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Clofarabine.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Clofarabine.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AC21, treprostinil, Clofarabine may increase the hypotensive activities of Treprostinil.]
[H03BC01, potassium perchlorate, Clofarabine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Clofarabine may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Pramocaine.]
[C08DB01, diltiazem, The risk or severity of adverse effects can be increased when Diltiazem is combined with Clofarabine.]
[V03AB09, dimercaprol, Clofarabine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Clofarabine may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[G02AD02, dinoprostone, The serum concentration of Clofarabine can be increased when it is combined with Dinoprostone.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Diphenhydramine.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Clofarabine is combined with Quinapril.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dipyridamole.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Clofarabine.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Clofarabine.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Clofarabine is combined with Sirolimus.]
[S01AX06, resorcinol, Clofarabine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The serum concentration of Clofarabine can be increased when it is combined with Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Natalizumab.]
[N05AX08, risperidone, Clofarabine may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, Clofarabine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Clofarabine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Ropivacaine.]
[L01EX01, sunitinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Sunitinib.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Clofarabine.]
[G04BE08, tadalafil, Clofarabine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C02KX02, ambrisentan, Clofarabine may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, The serum concentration of Clofarabine can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[R03AC12, salmeterol, The serum concentration of Clofarabine can be increased when it is combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C01CA07, dobutamine, Clofarabine may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, The serum concentration of Clofarabine can be increased when it is combined with Dopamine.]
[N06AA12, doxepin, Clofarabine may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Doxorubicin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Clofarabine is combined with Sevoflurane.]
[A08AA10, sibutramine, Clofarabine may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Clofarabine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, Clofarabine may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, Clofarabine may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Clofarabine may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Clofarabine may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Clofarabine may increase the hypotensive activities of Talinolol.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Clofarabine can be decreased when combined with Tazobactam.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Temozolomide.]
[M01AC02, tenoxicam, The excretion of Clofarabine can be decreased when combined with Tenoxicam.]
[G04CA03, terazosin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Terazosin.]
[C09AA02, enalapril, The excretion of Clofarabine can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Clofarabine.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Trandolapril is combined with Clofarabine.]
[N05CC01, chloral hydrate, Clofarabine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Clofarabine.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Clofarabine is combined with Trilostane.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Clofarabine.]
[C02CA06, urapidil, Clofarabine may increase the hypotensive activities of Urapidil.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Clofarabine.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Barnidipine.]
[S01EA01, epinephrine, The serum concentration of Clofarabine can be increased when it is combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Clofarabine.]
[C09AA15, zofenopril, Clofarabine may increase the hypotensive activities of Zofenopril.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Clofarabine.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Carboplatin.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Guanfacine.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Clofarabine is combined with Iloprost.]
[N03AG01, valproic acid, The excretion of Clofarabine can be decreased when combined with Valproic acid.]
[L03AX05, pidotimod, Clofarabine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Clofarabine may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, The excretion of Clofarabine can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The serum concentration of Clofarabine can be increased when it is combined with Estradiol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Estramustine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Clofarabine can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluticasone.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01CB01, etoposide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Etoposide.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Clofarabine.]
[P01AX07, trimetrexate, Clofarabine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The serum concentration of Clofarabine can be increased when it is combined with Bupropion.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Clofarabine.]
[C10AA03, pravastatin, The excretion of Clofarabine can be decreased when combined with Pravastatin.]
[B05AA05, dextran, Clofarabine may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Clofarabine.]
[A02BA03, famotidine, The serum concentration of Clofarabine can be increased when it is combined with Famotidine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C08CA02, felodipine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Felodipine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N02AB03, fentanyl, Clofarabine may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Clofarabine may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Clofarabine.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Antilymphocyte immunoglobulin (horse).]
[S01AA13, fusidic acid, Fusidic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Clofarabine.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Clofarabine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluticasone furoate.]
[M01CB01, gold sodium thiomalate, Clofarabine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Clofarabine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[G04BD02, flavoxate, Clofarabine may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fludrocortisone.]
[V03AB25, flumazenil, Clofarabine may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluocinonide.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Fluocortolone.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Clofarabine.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Clofarabine.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Clofarabine.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Clofarabine.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Clofarabine.]
[N05CD01, flurazepam, The serum concentration of Clofarabine can be increased when it is combined with Flurazepam.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[S02AA17, fosfomycin, Clofarabine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01BC03, tegafur, Clofarabine may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Clofarabine.]
[C03CA01, furosemide, The excretion of Clofarabine can be decreased when combined with Furosemide.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[S01AD09, ganciclovir, The excretion of Clofarabine can be decreased when combined with Ganciclovir.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Clofarabine.]
[C10AB04, gemfibrozil, The excretion of Clofarabine can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Clofarabine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dasatinib.]
[A10BB07, glipizide, Clofarabine may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Dexmedetomidine.]
[C05AE01, nitroglycerin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nitroglycerin.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Clofarabine.]
[L01EX02, sorafenib, The risk or severity of adverse effects can be increased when Sorafenib is combined with Clofarabine.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Esmolol is combined with Clofarabine.]
[M01CB04, aurothioglucose, Clofarabine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Clofarabine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Fluindione is combined with Clofarabine.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Clofarabine.]
[S01EX01, guanethidine, Clofarabine may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Clofarabine is combined with Halothane.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Quetiapine.]
[N06BX13, idebenone, Clofarabine may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Irinotecan.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Clofarabine.]
[C09CA01, losartan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Losartan.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Clofarabine.]
[G03DC01, allylestrenol, Clofarabine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Clofarabine.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Clofarabine.]
[C08CA10, nilvadipine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Nimesulide is combined with Clofarabine.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Clofarabine is combined with Perindopril.]
[C02DB02, hydralazine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Clofarabine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[G04BD06, propiverine, Clofarabine may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Hydroxychloroquine.]
[B05AA07, hetastarch, Clofarabine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Clofarabine is combined with Hydroxyurea.]
[C02AC06, rilmenidine, Clofarabine may increase the hypotensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The excretion of Clofarabine can be decreased when combined with Ibuprofen.]
[B05XA08, sodium acetate, Clofarabine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Clofarabine.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ifosfamide.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Clofarabine is combined with Sufentanil.]
[N06AA02, imipramine, The serum concentration of Clofarabine can be increased when it is combined with Imipramine.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Clofarabine is combined with Paclitaxel.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Tixocortol.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Tizanidine.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Topotecan.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Clofarabine.]
[C02CA02, indoramin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Indoramin.]
[A11HA07, inositol, Clofarabine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Clofarabine.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Clofarabine.]
[N06AX17, milnacipran, Clofarabine may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, The serum concentration of Clofarabine can be increased when it is combined with Varenicline.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Articaine.]
[A10BH01, sitagliptin, Clofarabine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N05CH02, ramelteon, Clofarabine may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[L01XX35, anagrelide, The risk or severity of bleeding can be increased when Anagrelide is combined with Clofarabine.]
[C07AA01, alprenolol, Clofarabine may increase the hypotensive activities of Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Clofarabine.]
[V03AB01, ipecac, Clofarabine may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Clofarabine.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Clofarabine.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Clofarabine is combined with Imidapril.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Clofarabine is combined with Isoflurane.]
[J04AC01, isoniazid, Clofarabine may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Clofarabine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Clofarabine is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Clofarabine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Isoxsuprine.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Clofarabine.]
[S01AA24, kanamycin, Clofarabine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Tocilizumab.]
[N01AX03, ketamine, Clofarabine may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Clofarabine.]
[B01AC22, prasugrel, The risk or severity of bleeding can be increased when Prasugrel is combined with Clofarabine.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Clofarabine.]
[M02AA10, ketoprofen, The excretion of Clofarabine can be decreased when combined with Ketoprofen.]
[L04AA24, abatacept, The risk or severity of adverse effects can be increased when Clofarabine is combined with Abatacept.]
[N04BC09, rotigotine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Rotigotine.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Labetalol is combined with Clofarabine.]
[N04BB01, amantadine, The serum concentration of Clofarabine can be increased when it is combined with Amantadine.]
[C02AA05, deserpidine, Clofarabine may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Clofarabine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Clofarabine.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Clofarabine is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Lidocaine.]
[S01AA21, amikacin, Clofarabine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, The serum concentration of Clofarabine can be increased when it is combined with Amiloride.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Lomustine.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Clofarabine is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Clofarabine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Clofarabine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pralatrexate.]
[L01EA03, nilotinib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Clofarabine may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Mecamylamine.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Clofarabine.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Clofarabine.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Clofarabine.]
[N05CH01, melatonin, The excretion of Clofarabine can be decreased when combined with Melatonin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Melphalan.]
[N06DX01, memantine, Clofarabine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Clofarabine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Mepivacaine.]
[G04BX16, tiopronin, Clofarabine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Clofarabine may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06BA03, methamphetamine, Clofarabine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Clofarabine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The risk or severity of adverse effects can be increased when Clofarabine is combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pemetrexed.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Clofarabine.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Methotrexate is combined with Clofarabine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of adverse effects can be increased when Clofarabine is combined with Methyldopa.]
[V04CG05, methylene blue, The serum concentration of Clofarabine can be increased when it is combined with Methylene blue.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Methylprednisolone.]
[G03EK01, methyltestosterone, The excretion of Clofarabine can be increased when combined with Methyltestosterone.]
[A03FA01, metoclopramide, Clofarabine may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The serum concentration of Clofarabine can be increased when it is combined with Metoprolol.]
[V04CD01, metyrapone, Clofarabine may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Clofarabine.]
[N05CD08, midazolam, Clofarabine may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Clofarabine.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of adverse effects can be increased when Valsartan is combined with Clofarabine.]
[J01AA08, minocycline, The excretion of Clofarabine can be decreased when combined with Minocycline.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Clofarabine.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clofarabine.]
[C01BD01, amiodarone, The serum concentration of Clofarabine can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Clofarabine.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Certolizumab pegol.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[G04BA01, ammonium chloride, Clofarabine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Ofatumumab.]
[L01EX03, pazopanib, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pazopanib.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Clofarabine is combined with Mycophenolic acid.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Clofarabine.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Clofarabine.]
[C07AA12, nadolol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nadolol.]
[J01CA04, amoxicillin, Clofarabine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Clofarabine.]
[V03AB15, naloxone, Clofarabine may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[L04AC03, anakinra, The risk or severity of adverse effects can be increased when Anakinra is combined with Clofarabine.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Clofarabine is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Clofarabine.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Clofarabine.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Clofarabine is combined with Docetaxel.]
[S03AA01, neomycin, Clofarabine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Clofarabine is combined with Remifentanil.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Levosimendan.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Clofarabine.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Clofarabine is combined with Amphotericin B.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L03AX16, plerixafor, Clofarabine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Clofarabine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Clofarabine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Clofarabine can be decreased when combined with Febuxostat.]
[C01CE01, inamrinone, Clofarabine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Clofarabine.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Clofarabine.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Nicardipine is combined with Clofarabine.]
[N07BA01, nicotine, The serum concentration of Clofarabine can be increased when it is combined with Nicotine.]
[C08CA05, nifedipine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nifedipine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Clofarabine is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of adverse effects can be increased when Nimodipine is combined with Clofarabine.]
[C08CA07, nisoldipine, The risk or severity of adverse effects can be increased when Nisoldipine is combined with Clofarabine.]
[C08CA08, nitrendipine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Clofarabine.]
[J01XE01, nitrofurantoin, Clofarabine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Clofarabine may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Clofarabine.]
[C02DD01, nitroprusside, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Clofarabine.]
[C01CA03, norepinephrine, The serum concentration of Clofarabine can be increased when it is combined with Norepinephrine.]
[C02KX01, bosentan, Clofarabine may increase the hypotensive activities of Bosentan.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Clofarabine.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Clofarabine.]
[L04AC04, rilonacept, The risk or severity of adverse effects can be increased when Clofarabine is combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N02AA02, opium, Clofarabine may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Clofarabine.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Clofarabine.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Clofarabine is combined with Tamsulosin.]
[C01AC01, ouabain, The excretion of Clofarabine can be decreased when combined with Ouabain.]
[J01CF04, oxacillin, Clofarabine may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Clofarabine may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, The serum concentration of Clofarabine can be increased when it is combined with Oxprenolol.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[S01AA04, oxytetracycline, The excretion of Clofarabine can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The serum concentration of Clofarabine can be increased when it is combined with Aminohippuric acid.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Clofarabine.]
[J04AB30, capreomycin, Clofarabine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Papaverine.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Clofarabine.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[G04BD11, fesoterodine, Clofarabine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Penbutolol.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Clofarabine can be decreased when combined with Benzylpenicillin.]
[J01CE09, penicillin G procaine, Clofarabine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Clofarabine.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Clofarabine.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Clofarabine.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Clofarabine.]
[C04AD03, pentoxifylline, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Clofarabine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Clofarabine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Clofarabine.]
[A10BA01, phenformin, The serum concentration of Clofarabine can be increased when it is combined with Phenformin.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Phenindione is combined with Clofarabine.]
[N03AA02, phenobarbital, Phenobarbital may increase the hypotensive activities of Clofarabine.]
[C04AX02, phenoxybenzamine, The serum concentration of Clofarabine can be increased when it is combined with Phenoxybenzamine.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Phenprocoumon is combined with Clofarabine.]
[V03AB36, phentolamine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Phentolamine.]
[M02AA01, phenylbutazone, The excretion of Clofarabine can be decreased when combined with Phenylbutazone.]
[L04AB06, golimumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Golimumab.]
[S01AE05, levofloxacin, Clofarabine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Clofarabine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C08CX01, mibefradil, Clofarabine may increase the hypotensive activities of Mibefradil.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Pindolol.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J05AE01, saquinavir, Saquinavir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N06BX03, piracetam, Clofarabine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Eprosartan.]
[S01BC06, piroxicam, The excretion of Clofarabine can be decreased when combined with Piroxicam.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J01MA11, grepafloxacin, The serum concentration of Clofarabine can be increased when it is combined with Grepafloxacin.]
[C09CA04, irbesartan, The risk or severity of adverse effects can be increased when Clofarabine is combined with Irbesartan.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Clofarabine.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Clofarabine.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AC08, canakinumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, Ritonavir may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[A10BH03, saxagliptin, Clofarabine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Clofarabine may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[C07AB01, practolol, Clofarabine may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Prazosin is combined with Clofarabine.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Clofarabine is combined with Prednisone.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Prilocaine.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Clofarabine.]
[M04AB01, probenecid, The serum concentration of Clofarabine can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, The serum concentration of Clofarabine can be increased when it is combined with Procainamide.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Procarbazine.]
[C10AB05, fenofibrate, Clofarabine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03DA04, progesterone, The serum concentration of Clofarabine can be increased when it is combined with Progesterone.]
[R06AD02, promethazine, Clofarabine may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Clofarabine may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Propofol.]
[C07AA05, propranolol, The serum concentration of Clofarabine can be increased when it is combined with Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Clofarabine.]
[N02CC04, rizatriptan, Clofarabine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Clofarabine is combined with Epoprostenol.]
[N05AX12, aripiprazole, Aripiprazole may increase the hypotensive activities of Clofarabine.]
[N07XX07, dalfampridine, Clofarabine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Clofarabine may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Clofarabine.]
[P01AX05, quinacrine, The serum concentration of Clofarabine can be increased when it is combined with Quinacrine.]
[C01BA01, quinidine, The serum concentration of Clofarabine can be increased when it is combined with Quinidine.]
[P01BC01, quinine, The serum concentration of Clofarabine can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, The serum concentration of Clofarabine can be increased when it is combined with Ranitidine.]
[C02AA01, rescinnamine, Clofarabine may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Clofarabine.]
[J05AP01, ribavirin, Clofarabine may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, The excretion of Clofarabine can be decreased when combined with Rifampicin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The excretion of Clofarabine can be decreased when combined with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Clofarabine.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Clofarabine.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Clofarabine is combined with Obinutuzumab.]
[J01GB08, sisomicin, Clofarabine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Clofarabine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Clofarabine.]
[V04CC01, sorbitol, Clofarabine may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Clofarabine.]
[L01CD04, cabazitaxel, The risk or severity of adverse effects can be increased when Clofarabine is combined with Cabazitaxel.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Clofarabine.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Clofarabine is combined with Hydrocortisone butyrate.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Clofarabine is combined with Isosorbide mononitrate.]
[H02CA04, levoketoconazole, The serum concentration of Clofarabine can be increased when it is combined with Levoketoconazole.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
